Author

N. E. Campillo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2 Approach:statistical model· 2 Organism:human· 1 Organism:zebrafish· 1

Frequent Co-Authors

A. Martinez· 2 shared A. Garcia-Rubia· 1 shared A. M. Gomez Pozo· 1 shared A. Quijada-Freire· 1 shared B. Soler Palacios· 1 shared C. Gil· 1 shared C. Oscar Sorzano· 1 shared C. Roca· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

A. Martinez

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domain

E. M. Garcia-Cuesta, P. Martinez, K. Selvaraju, G. Ulltjärn, A. M. Gomez Pozo, G. D'Agostino, S. Gardeta, A. Quijada-Freire, P. Blanco Gabella, C. Roca, D. del Hoyo, R. Jimenez-Saiz, A. Garcia-Rubia, B. Soler Palacios, P. Lucas, , M. Mellado

This paper identifies a small molecule that modulates CXCR4 nanoclustering without affecting ligand binding, improving therapeutic potential over existing CXCR4 antagonists.

bioRxiv · Nov 19, 2023Cell Biology

Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical in silico/in vitro screening methods

T. Ginez, U. Garaigorta, D. Ramirez, V. Castro, V. Nozal, I. Maestro, J. Garcia-Carceles, N. E. Campillo, A. Martinez, P. Gastaminza, C. Gil

The paper identifies five FDA-approved drugs with antiviral activity against SARS-CoV-2 using a combined in silico and in vitro screening approach.

bioRxiv · Nov 26, 2020Microbiology